NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
16/10/2024
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS
ST13
US500000086794366Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Localização atual
Titulares
Representantes
Susan A. Smith Ballard Spahr LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
clinical research site management and monitoring, namely, identifying, qualifying, and selecting sites for clinical trials, negotiating clinical trial site contracts and budgets, organizing and conducting business meetings of clinical trial investigators, assisting investigators with developing business strategies for recruiting clinical trial participants, submitting clinical trial protocols to institutional review boards and independent ethics committees, monitoring clinical trial investigators' activities for compliance with clinical protocols and regulations and for patient safety; employment staffing in the field of clinical trials; business information management; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, pharmaceutical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; business project management in the field of clinical trials; providing the services of vendor management to medical, pharmaceutical, biopharmaceutical and biotechnology companies, namely, selecting and managing third-party providers of services that support clinical trials
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
16/10/2024
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
16/10/2024
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
16/10/2024
TEAS SECTION 8 & 15 RECEIVED
17/04/2024
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
27/11/2023
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/09/2022
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/09/2022
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/09/2022
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/09/2022
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/09/2022
REGISTERED-PRINCIPAL REGISTER
27/11/2018
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/10/2018
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/10/2018
STATEMENT OF USE PROCESSING COMPLETE
25/10/2018
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/10/2018
USE AMENDMENT FILED
01/10/2018
TEAS STATEMENT OF USE RECEIVED
01/10/2018
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15/03/2018
SOU EXTENSION 1 GRANTED
13/03/2018
SOU EXTENSION 1 FILED
13/03/2018
SOU TEAS EXTENSION RECEIVED
13/03/2018
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28/11/2017
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
18/10/2017
TEAS CHANGE OF OWNER ADDRESS RECEIVED
18/10/2017
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2017
PUBLISHED FOR OPPOSITION
03/10/2017
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/09/2017
APPROVED FOR PUB - PRINCIPAL REGISTER
28/08/2017
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
22/08/2017
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/02/2017
LETTER OF SUSPENSION E-MAILED
16/02/2017
SUSPENSION LETTER WRITTEN
16/02/2017
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2017
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2017
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
08/02/2017
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
16/12/2016
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
16/06/2016
LETTER OF SUSPENSION E-MAILED
16/06/2016
SUSPENSION LETTER WRITTEN
16/06/2016
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2016
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2016
ASSIGNED TO LIE
02/06/2016
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/05/2016
NOTIFICATION OF NON-FINAL ACTION E-MAILED
19/02/2016
NON-FINAL ACTION E-MAILED
19/02/2016
NON-FINAL ACTION WRITTEN
19/02/2016
ASSIGNED TO EXAMINER
11/02/2016
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/10/2015
NEW APPLICATION ENTERED
24/10/2015
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.